Tag Archives: Paras N. Prasad

A new nanoparticle—layered* like an onion

The new nanoparticle comes courtesy of an international collaboration (US, China, Sweden, and Russia. A Nov. 10, 2015 University of Buffalo news release (also on EurekAlert) by Charlotte Hu describes the particle and its properties,

A new, onion-like nanoparticle could open new frontiers in biomaging, solar energy harvesting and light-based security techniques.

The particle’s innovation lies in its layers: a coating of organic dye, a neodymium-containing shell, and a core that incorporates ytterbium and thulium. Together, these strata convert invisible near-infrared light to higher energy blue and UV light with record-high efficiency, a trick that could improve the performance of technologies ranging from deep-tissue imaging and light-induced therapy to security inks used for printing money.

Here’s an artist’s representation of the new nanoparticle,

An artist’s rendering shows the layers of a new, onion-like nanoparticle whose specially crafted layers enable it to efficiently convert invisible near-infrared light to higher energy blue and UV light. Credit: Kaiheng Wei Courtesy: University of Buffalo

An artist’s rendering shows the layers of a new, onion-like nanoparticle whose specially crafted layers enable it to efficiently convert invisible near-infrared light to higher energy blue and UV light. Credit: Kaiheng Wei Courtesy: University of Buffalo

The news release goes on to describe technology in more detail,

When it comes to bioimaging, near-infrared light could be used to activate the light-emitting nanoparticles deep inside the body, providing high-contrast images of areas of interest. In the realm of security, nanoparticle-infused inks could be incorporated into currency designs; such ink would be invisible to the naked eye, but glow blue when hit by a low-energy laser pulse — a trait very difficult for counterfeiters to reproduce.

“It opens up multiple possibilities for the future,” says Tymish Ohulchanskyy, deputy director of photomedicine and research associate professor at the Institute for Lasers, Photonics, and Biophotonics (ILPB) at the University at Buffalo.

“By creating special layers that help transfer energy efficiently from the surface of the particle to the core, which emits blue and UV light, our design helps overcome some of the long-standing obstacles that previous technologies faced,” says Guanying Chen, professor of chemistry at Harbin Institute of Technology [China] and ILPB research associate professor.

“Our particle is about 100 times more efficient at ‘upconverting’ light than similar nanoparticles created in the past, making it much more practical,” says Jossana Damasco, a UB chemistry PhD student who played a key role in the project.

The research was published online in Nano Letters on Oct. 21 and led by the Institute for Lasers, Photonics, and Biophotonics at UB, and the Harbin Institute of Technology in China, with contributions from the Royal Institute of Technology in Sweden; Tomsk State University in Russia; and the University of Massachusetts Medical School.

The study’s senior author was Paras Prasad, ILPB executive director and SUNY [State University of New York] Distinguished Professor in chemistry, physics, medicine and electrical engineering at UB.

Peeling back the layers

Converting low-energy light to light of higher energies isn’t easy to do. The process involves capturing two or more tiny packets of light called “photons” from a low-energy light source, and combining their energy to form a single, higher-energy photon.

The onionesque nanoparticle performs this task beautifully. Each of its three layers fulfills a unique function:

  • The outermost layer is a coating of organic dye. This dye is adept at absorbing photons from low-energy near-infrared light sources. It acts as an “antenna” for the nanoparticle, harvesting light and transferring energy inside, Ohulchanskyy says.
  • The next layer is a neodymium-containing shell. This layer acts as a bridge, transferring energy from the dye to the particle’s light-emitting core.
  • Inside the light-emitting core, ytterbium and thulium ions work in concert. The ytterbium ions draw energy into the core and pass the energy on to the thulium ions, which have special properties that enable them to absorb the energy of three, four or five photons at once, and then emit a single higher-energy photon of blue and UV light.

So why not just use the core? Why add the dye and neodymium layer at all?

As Ohulchanskyy and Chen explain, the core itself is inefficient in absorbing photons from the outside world. That’s where the dye comes in.

Once you add the dye, the neodymium-containing layer is necessary for transferring energy efficiently from dye to core. Ohulchanskyy uses the analogy of a staircase to explain why this is: When molecules or ions in a material absorb a photon, they enter an “excited” state from which they can transfer energy to other molecules or ions. The most efficient transfer occurs between molecules or ions whose excited states require a similar amount of energy to obtain, but the dye and ytterbium ions have excited states with very different energies. So the team added neodymium — whose excited state is in between that of the dye and thulium’s — to act as a bridge between the two, creating a “staircase” for the energy to travel down to reach emitting thulium ions.

Here’s a link to and a citation for the paper,

Energy-Cascaded Upconversion in an Organic Dye-Sensitized Core/Shell Fluoride Nanocrystal by Guanying Chen, Jossana Damasco, Hailong Qiu, Wei Shao, Tymish Y. Ohulchanskyy, Rashid R. Valiev, Xiang Wu, Gang Han, Yan Wang, Chunhui Yang, Hans Ågren, and Paras N. Prasad. Nano Lett., 2015, 15 (11), pp 7400–7407 DOI: 10.1021/acs.nanolett.5b02830 Publication Date (Web): October 21, 2015

Copyright © 2015 American Chemical Society

This paper is behind a paywall.

Finally, there is a Nov. 11, 2015 article about the research by Jake Wilkinson for Azonano. He provides additional details such as this measurement,

Measuring approximately 50nm in diameter, the new nanoparticle features three differently designed layers. …

*’ayered’ changed to ‘layered’ on Nov. 11, 2015.

A nanoparticle for a medical imaging machine that doesn’t exist yet

Researchers at the University of Buffalo (New York state) have created a nanoparticle that can be detected by six imaging devices according to a Jan. 20, 2015 news item on ScienceDaily,

It’s technology so advanced that the machine capable of using it doesn’t yet exist.

Using two biocompatible parts, University at Buffalo researchers and their colleagues have designed a nanoparticle that can be detected by six medical imaging techniques:

• computed tomography (CT) scanning;

• positron emission tomography (PET) scanning;

• photoacoustic imaging;

• fluorescence imaging;

• upconversion imaging; and

• Cerenkov luminescence imaging.

The advantages are obvious should somebody, somewhere create a hexamodal (aka, multimodal, aka hypmodal) sensing device capable of exploiting the advantages of this nanoparticle as the researchers hope.

A Jan. 20, 2015 University of Buffalo news release (also on EurekAlert) by Charlotte Hsu, which originated the news item, describes the ideas underlying the research,

This kind of “hypermodal” imaging — if it came to fruition — would give doctors a much clearer picture of patients’ organs and tissues than a single method alone could provide. It could help medical professionals diagnose disease and identify the boundaries of tumors.

“This nanoparticle may open the door for new ‘hypermodal’ imaging systems that allow a lot of new information to be obtained using just one contrast agent,” says researcher Jonathan Lovell, PhD, UB assistant professor of biomedical engineering. “Once such systems are developed, a patient could theoretically go in for one scan with one machine instead of multiple scans with multiple machines.”

When Lovell and colleagues used the nanoparticles to examine the lymph nodes of mice, they found that CT and PET scans provided the deepest tissue penetration, while the photoacoustic imaging showed blood vessel details that the first two techniques missed.

Differences like these mean doctors can get a much clearer picture of what’s happening inside the body by merging the results of multiple modalities.

A machine capable of performing all six imaging techniques at once has not yet been invented, to Lovell’s knowledge, but he and his coauthors hope that discoveries like theirs will spur development of such technology.

The news release also offers a description of the nanoparticles,

The researchers designed the nanoparticles from two components: An “upconversion” core that glows blue when struck by near-infrared light, and an outer fabric of porphyrin-phospholipids (PoP) that wraps around the core.

Each part has unique characteristics that make it ideal for certain types of imaging.

The core, initially designed for upconversion imaging, is made from sodium, ytterbium, fluorine, yttrium and thulium. The ytterbium is dense in electrons — a property that facilitates detection by CT scans.

The PoP wrapper has biophotonic qualities that make it a great match for fluorescence and photoacoustic imagining. The PoP layer also is adept at attracting copper, which is used in PET and Cerenkov luminescence imaging.

“Combining these two biocompatible components into a single nanoparticle could give tomorrow’s doctors a powerful, new tool for medical imaging,” says Prasad, also a SUNY Distinguished Professor of chemistry, physics, medicine and electrical engineering at UB. “More studies would have to be done to determine whether the nanoparticle is safe to use for such purposes, but it does not contain toxic metals such as cadmium that are known to pose potential risks and found in some other nanoparticles.”

“Another advantage of this core/shell imaging contrast agent is that it could enable biomedical imaging at multiple scales, from single-molecule to cell imaging, as well as from vascular and organ imaging to whole-body bioimaging,” Chen adds. “These broad, potential capabilities are due to a plurality of optical, photoacoustic and radionuclide imaging abilities that the agent possesses.”

Lovell says the next step in the research is to explore additional uses for the technology.

For example, it might be possible to attach a targeting molecule to the PoP surface that would enable cancer cells to take up the particles, something that photoacoustic and fluorescence imaging can detect due to the properties of the smart PoP coating. This would enable doctors to better see where tumors begin and end, Lovell says.

The researchers have provided two images,

This transmission electron microscopy image shows the nanoparticles, which consist of a core that glows blue when struck by near-infrared light, and an outer fabric of porphyrin-phospholipids (PoP) that wraps around the core. Credit: Jonathan Lovell

This transmission electron microscopy image shows the nanoparticles, which consist of a core that glows blue when struck by near-infrared light, and an outer fabric of porphyrin-phospholipids (PoP) that wraps around the core.
Credit: Jonathan Lovell

University at Buffalo researchers and colleagues have designed a nanoparticle detectable by six medical imaging techniques. This illustration depicts the particles as they are struck by beams of energy and emit signals that can be detected by the six methods: CT and PET scanning, along with photoacoustic, fluorescence, upconversion and Cerenkov luminescence imaging. Credit: Jonathan Lovell

University at Buffalo researchers and colleagues have designed a nanoparticle detectable by six medical imaging techniques. This illustration depicts the particles as they are struck by beams of energy and emit signals that can be detected by the six methods: CT and PET scanning, along with photoacoustic, fluorescence, upconversion and Cerenkov luminescence imaging.
Credit: Jonathan Lovell

Here’s a link to and a citation for the paper,

Hexamodal Imaging with Porphyrin-Phospholipid-Coated Upconversion Nanoparticles by James Rieffel, Feng Chen, Jeesu Kim, Guanying Chen, Wei Shao, Shuai Shao, Upendra Chitgupi, Reinier Hernandez, Stephen A. Graves, Robert J. Nickles, Paras N. Prasad, Chulhong Kim, Weibo Cai, and Jonathan F. Lovell. Advanced Materials DOI: 10.1002/adma.201404739 Article first published online: 14 JAN 2015

© 2015 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim

This article is behind a paywall.

More on quantum dots: a toxicity study; Merck action in Israel

I have two items on quantum dots today. The first concerns a toxicity study performed on primates at the University of Buffalo (NY, USA). From the May 22, 2012 news item by Will Soutter for Azonano,

A multi-institute toxicity study on quantum dots in primates has discovered that these nanocrystals are safe for a period of one year.

This finding is encouraging for researchers and physicians looking for novel techniques to treat diseases such as cancer using nanomedicine. The organizations involved in the study included the University at Buffalo, Nanyang Technological University, ChangChun University of Science and Technology, and the Chinese PLA General Hospital.

On digging a little further, I found this information on the University of Buffalo website, from their May 21, 2012 news release,

— Tiny luminescent crystals called quantum dots hold great promise as tools for treating and detecting diseases like cancer.

— A pioneering study to gauge the toxicity of quantum dots in primates has found cadmium-selenide quantum dots to be safe over intervals of time ranging from three months to a year. The study is likely the first to test the safety of quantum dots in primates.

— The authors say more research is needed to determine quantum dots’ long-term effect on health; elevated levels of cadmium from the quantum dots were found in the primates even after 90 days.

The research, which appeared on May 20 in Nature Nanotechnology online , is likely the first to test the safety of quantum dots in primates.

In the study, scientists found that four rhesus monkeys injected with cadmium-selenide quantum dots remained in normal health over 90 days. Blood and biochemical markers stayed in typical ranges, and major organs developed no abnormalities. The animals didn’t lose weight.

Two monkeys observed for an additional year also showed no signs of illness.

The first  results are hopeful but there are some concerns,

The new toxicity study — completed by the University at Buffalo, the Chinese PLA General Hospital, China’s ChangChun University of Science and Technology, and Singapore’s Nanyang Technological University — begins to address the concern of health professionals who worry that quantum dots may be dangerous to humans.

The authors caution, however, that more research is needed to determine the nanocrystals’ long-term effects in primates; most of the potentially toxic cadmium from the quantum dots stayed in the liver, spleen and kidneys of the animals studied over the 90-day period.

The cadmium build-up, in particular, is a serious concern that warrants further investigation, said Ken-Tye Yong, a Nanyang Technological University assistant professor who began working with Prasad [Paras N. Prasad] on the study as a postdoctoral researcher at UB.

Unusually, this article seems to be open access at Nature Nanotechnology,

A pilot study in non-human primates shows no adverse response to intravenous injection of quantum dots

Ling Ye, Ken-Tye Yong, Liwei Liu, Indrajit Roy, Rui Hu, Jing Zhu, Hongxing Cai, Wing-Cheung Law, Jianwei Liu, Kai Wang, Jing Liu, Yaqian Liu, Yazhuo Hu, Xihe Zhang, Mark T. Swihart, and Paras N. Prasad

Nature Nanotechnology (2012) doi:10.1038/nnano.2012.74

The acquisition of an Israeli quantum dot company by Merck is my second bit of quantum dot news, from the May 22, 2012 news item on Nanowerk,

Merck announced today that within the scope of a capital increase by the Israeli start-up company QLight Nanotech, it is acquiring an interest in the Jerusalem-based company. QLight Nanotech is a spin-off subsidiary of Yissum, the technology transfer company of the Hebrew University of Jerusalem. QLight Nanotech develops products for use in displays and energy-efficient light sources based on semiconductor nanoparticles known as quantum dots.

I understood that Merck was a pharmaceutical company so I was bit surprised to see this (from the May 22, 2012 news item on the Solid State Technology website)

“I am excited that our basic science discoveries on semiconductor nanocrystals are now being realized in innovative technological applications. The partnership with Merck, a world leader in materials for display applications, is a synergistic one allowing us at Qlight Nanotech to implement advanced chemicals manufacturing and applications’ know-how,” said the scientific founder of  QLight Nanotech, Professor Uri Banin of the Hebrew University of Jerusalem, who will continue to support the company as a shareholder and advisor alongside of Yissum.

In fact, Merck bills itself as a pharmaceuticals and a s chemicals company.